Respiratory Infections, Acute Completed Phase 3 Trials for Hydroxychloroquine (DB01611)

Also known as: Acute Infection Respiratory / Acute Respiratory Infections / Acute Respiratory Infection

IndicationStatusPhase
DBCOND0031056 (Respiratory Infections, Acute)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04332991Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic DiseaseTreatment